Browse by Medical Category
Accepting New Patients
Go To Programs
Go To Programs
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
View my most recent publications at PubMed
Saylor P, Kaufman D, Michaelson D, Lee R, Smith M. Application of the WHO/FRAX fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer. Journal of Urology. 2010 Jun; 183(6):2200-5. Saylor P, Fogerty A. Prostate cancer associated hypercoagulability: do we need to worry about androgen deprivation? Lancet Oncology. 2010 May; 11(5):406-7. Saylor P, Smith M. Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health among Men with Prostate Cancer. Journal of the National Comprehensive Cancer Network. 2010 Feb; 8(2): 211-23. Saylor P, Smith M. Review: Bone Health and Prostate Cancer. Prostate Cancer and Prostatic Diseases. 2009 Mar; 13(1):20-7. Saylor P, Keating N, Smith M. Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy. Journal of General Internal Medicine. 2009 Nov; 24(2): 389-94. Saylor P, Smith M. Prostate Cancer: How can we improve the health of men who receive ADT? Nature Reviews Urology. 2009 Oct; 6(10): 529-31. Saylor P, Michaelson M. New Treatments for Renal Cell Carcinoma: Targeted Therapies. Journal of the National Comprehensive Cancer Network. 2009; 7(6): 645-56. Saylor P, Smith M. Metabolic complications of androgen deprivation therapy for prostate cancer. Journal of Urology. 2009 May; 181 (5): 1998-2006. Saylor P, Reid T. Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib. Journal of Clinical Oncology. 2007 Aug 10; 25 (23): 3544-3546.
quotes MGH physician Phillip Saylor
quotes MGH physician Philip Saylor
Back to Top